How to Reconstitute Palmitoyl Tetrapeptide-7: Laboratory Reconstitution Guide
The content, articles and product information provided on this website are strictly educational and informational. They are intended to be used for in vitro research only. “In vitro” is a Latin phrase, “in glass,” that refers to research that is conducted outside of a living organism. Note, these products are not pharmaceuticals or medicines and have not been approved by the FDA for the diagnosis, treatment or prevention of any illnesses or disorders. These products are legally prohibited from human or animal consumption.
How to Reconstitute Palmitoyl Tetrapeptide-7: Laboratory Reconstitution Guide
Palmitoyl Tetrapeptide-7 (Pal-GQPR, N-palmitoyl-Gly-Gln-Pro-Arg, MW 694.94 g/mol) is a lipopeptide studied in dermal fibroblast and skin cell model research for its cytokine pathway modulation and extracellular matrix signalling interactions. It is supplied as a lyophilised powder in a 10mL sterile glass vial containing 10mg. Like other palmitoyl-modified peptides, the fatty acid modification requires a co-solvent approach for complete aqueous reconstitution.
Materials Required
- Palmitoyl Tetrapeptide-7 10mg lyophilised vial
- Sterile ethanol (96%) for initial dissolution
- Bacteriostatic water (BAC water) for dilution to final volume
- 1mL or 2mL sterile syringe with needle
- Alcohol swabs (70% isopropyl)
- Nitrile gloves
- Permanent marker for labelling
Pre-Reconstitution Preparation
Inspect the vial for intact lyophilised powder and unbroken seal. Allow to equilibrate to room temperature for 15 minutes. The palmitoyl modification renders this peptide hydrophobic — it will not dissolve in aqueous media alone at research concentrations without ethanol co-solvent pre-wetting. Have both sterile ethanol and BAC water prepared and accessible before beginning.
Step-by-Step Reconstitution Protocol
Step 1 — Prepare workspace. Wipe work surface with 70% isopropyl alcohol. Allow to dry. Wear nitrile gloves throughout.
Step 2 — Swab vial stopper. Clean the rubber stopper with a fresh alcohol swab. Air dry 10 seconds.
Step 3 — Pre-wet with sterile ethanol. Draw 0.2mL of sterile 96% ethanol and inject slowly down the inner glass wall of the Pal-Tetra-7 vial. Swirl gently for 15–20 seconds — the palmitoyl peptide powder will begin to dissolve in ethanol more readily than in water.
Step 4 — Add BAC water to final volume. Draw 1.8mL of BAC water and add slowly along the vial wall (2mL total volume). Swirl gently for 30–60 seconds.
Step 5 — Inspect solution. The solution may appear slightly opalescent at 5mg/mL due to the lipophilic palmitoyl chain — this is expected. If visible particulate matter is present, continue gentle swirling for a further 30 seconds.
Step 6 — Label. Record reconstitution date, solvent (10% EtOH/BAC water), concentration, and initials.
Resulting Concentration
Adding 2mL total solvent (10% ethanol/BAC water) to a 10mg Pal-Tetra-7 vial yields a stock concentration of 5mg/mL. For dermal fibroblast IL-6 signalling and ECM pathway assay applications, working concentrations of 1ng/mL to 100mcg/mL are prepared by serial dilution into serum-free media. Always include matched ethanol vehicle controls.
Concentration Reference Table
| Total Volume | EtOH:BAC ratio | Concentration |
|---|---|---|
| 1mL | 0.1mL:0.9mL | 10.0mg/mL |
| 2mL | 0.2mL:1.8mL | 5.0mg/mL |
| 4mL | 0.4mL:3.6mL | 2.5mg/mL |
Storage Conditions and Stability
Store lyophilised Pal-Tetra-7 at −20°C prior to reconstitution, protected from light and moisture. Once reconstituted, store at 2–8°C for up to 14 days. Prepare small volumes to minimise storage duration of the ethanol-containing stock. For long-term aliquot storage, freeze single-use aliquots at −80°C.
Troubleshooting Common Reconstitution Issues
Powder not dissolving: Gently tilt and swirl to bring undissolved powder into contact with solvent. Do not heat. If incomplete after 60 seconds, inspect for moisture ingress or compromised seal.
Cloudy solution: Cloudiness may indicate aggregation or contamination. Discard if cloudiness persists after gentle swirling.
Foaming: Allow to settle naturally. Reduce injection speed on subsequent attempts and ensure stream is directed along the glass wall.
Loss of material: Swirl to contact all inner surfaces. Invert and draw from the stopper end for maximum recovery.
Research Application Notes
Palmitoyl Tetrapeptide-7 research in dermal fibroblast cell models focuses on interleukin-6 (IL-6) pathway modulation and downstream ECM gene expression including COL1A1, COL3A1, and MMP expression profiling. Include equivalent-concentration ethanol vehicle controls in all cell model assay conditions to account for any solvent effects on cytokine pathway endpoints. For comparative ECM pharmacology studies alongside PAL-GHK and GHK-Cu, matched concentration-response protocols in HDFa (human dermal fibroblast adult) cell preparations provide the most relevant skin cell biology research context. Palmitoyl Tetrapeptide-7 10mg vials are available from Pinnacle Peptides, verified at ≥99% purity by HPLC and mass spectrometry.
All content is intended for in vitro laboratory research purposes only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any condition.
